NewGenIvf Group Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Revenue	4.73	5.43	5.14	5.94
Revenue Growth (YoY)	-13.01%	5.79%	-13.59%	-
Cost of Revenue	3.77	3.61	3.45	4.41
Gross Profit	0.96	1.83	1.68	1.54
Selling, General & Admin	11.68	2.99	1.64	1.14
Total Operating Expenses	11.68	2.99	1.64	1.14
Operating Income	-10.73	-1.16	0.04	0.4
Interest Income	0	0.01	0	0
Interest Expense	-0.62	-0.78	-0.05	-0.08
Other Non-Operating Income (Expense)	23.14	0.97	0.11	0.02
Total Non-Operating Income (Expense)	22.52	0.2	0.07	-0.05
Pretax Income	9.73	-0.96	0.11	0.34
Provision for Income Taxes	-	-0.49	-	0.21
Net Income	9.73	-0.47	0.11	0.14
Minority Interest in Earnings	-0.15	0.05	-0.02	-0.32
Net Income to Common	9.88	-0.52	0.13	0.46
Net Income Growth	-	-	-71.61%	-
Shares Outstanding (Basic)	0	0	0	0
Shares Outstanding (Diluted)	1	0	0	0
Shares Change (YoY)	2731005.04%	23.98%	-	-
EPS (Basic)	644.25	-13227.60	39061.80	4248.85
EPS (Diluted)	9.12	-13227.60	39061.80	4248.85
EPS Growth	-	-	819.35%	-
Free Cash Flow	-11.06	-8.32	-1.84	1.62
Free Cash Flow Per Share	-10.21	-209696.00	-57391.90	50529.40
Gross Margin	20.22%	33.62%	32.74%	25.87%
Operating Margin	-226.95%	-21.36%	0.82%	6.71%
Profit Margin	205.84%	-8.73%	2.11%	2.29%
FCF Margin	-234.03%	-153.08%	-35.75%	27.19%
EBITDA	-10.23	-0.95	0.27	0.7
EBITDA Margin	-216.38%	-17.56%	5.29%	11.82%
EBIT	-10.73	-1.16	0.04	0.4
EBIT Margin	-226.95%	-21.36%	0.82%	6.71%
Effective Tax Rate	0.00%	50.66%	0.00%	60.51%

SEC Filings: 10-K · 10-Q